The very nature of infectious diseases has undergone profound changes in the past few decades. Fungi once considered as nonpathogenic or less virulent are now recognized as a primary cause of morbidity and mortality in immunocompromised and severely ill patients. Candida spp. are among the most common fungal pathogens. Candida albicans was the predominant cause of candidiasis. However, a shift toward non-albicans Candida species has been recently observed. These non-albicans Candida species demonstrate reduced susceptibility to commonly used antifungal drugs. In the present study, we investigated the prevalence of non-albicans Candida spp. among Candida isolates from various clinical specimens and analysed their virulence factors and antifungal susceptibility profile. A total of 523 Candida spp. were isolated from various clinical specimens. Non-albicans Candida species were the predominant pathogens isolated. Non-albicans Candida species also demonstrated the production of virulence factors once attributed to Candida albicans. Non-albicans Candida demonstrated high resistance to azole group of antifungal agents. Therefore, it can be concluded that non-albicans Candida species have emerged as an important cause of infections. Their isolation from clinical specimen can no longer be ignored as a nonpathogenic isolate nor can it be dismissed as a contaminant.

The incidence of invasive candidiasis has increased over the past few decades. Although Candida albicans remains by far the most common species encountered, in recent years shift towards non-albicans Candida species like Candida tropicalis is noted. Here in this study we determined the virulence factors and antifungal susceptibility profile of 125 C. tropicalis isolated from various clinical specimens. Biofilm formation was seen in 53 (42.4%) isolates. Coagulase production was noted in 18 (14.4%) isolates. Phospholipase enzyme was the major virulent factor produced by C. tropicalis isolates. A total of 39 biofilm forming isolates showed phospholipase activity. Proteinase activity was demonstrated by 65 (52%) isolates. A total of 38 (30.4%) isolates showed haemolytic activity. Maximum isolates demonstrated resistance to fluconazole. Fluconazole resistance was more common in C. tropicalis isolated from blood cultures. Antifungal resistance was more in isolates possessing the ability to produce phospholipase and biofilm. C. tropicalis exhibit a great degree of variation not only in their pathogenicity but also in their antifungal susceptibility profile. The identification of virulence attributes specific for each species and their correlation with each other will aid in the understanding of the pathogenesis of infection.

No abstract

Scope: Vancomycin-resistant enterococci (VRE) are being increasingly reported from hospitals across the world. This study provides a profile of enterococcal infections and compares various methods of detecting vancomycin resistance. Materials and Methods: All clinically significant isolates of enterococci over a 2-year period were included. Antibiotic susceptibility was carried out as per CLSI guidelines. Vancomycin resistance was detected by 3 methods: disk diffusion, agar screen, E-test. The 3 methods were compared. Results: 156 clinical samples yielded Enterococcus spp. over the study period. Maximum resistance was noted to penicillin, erythromycin, and ciprofloxacin. E. faecium strains showed a higher percentage of resistance to the antibiotics tested. 15 (9.6%) enterococcal strains were resistant to vancomycin; 10 (6.4%) strains were intermediate. Compared to E-test, disk diffusion and agar screen had sensitivities of 100%. Disk diffusion had 97.2% specificity and agar screen demonstrated 92.9% specificity. Conclusion: Prevalence of VRE in Indian hospitals is increasing. Though disk diffusion had a higher specificity than the agar screen at identifying resistant isolates, intermediate strains were identified as sensitive. BHI agar containing 6 µg/ml of vancomycin can be used to screen for VRE, and E-test can be used to confirm resistance.

No abstract

No abstract

Many people over the years have studied the Bible from a medical point of view offering diagnoses for the symptoms and signs that appear to have afflicted numerous individuals in the Bible. We review the biblical characters in the Old Testament and offer newer insights to their neurological diseases. We first look at the battle between Goliath and David. Interestingly, Goliath probably suffered from acromegaly. We propose autism as a diagnosis for Samson which would precede the first known case of autism by centuries. Isaac was a diabetic, and he probably had autonomic neuropathy. Few verses from the books of I Samuel, Psalms, and Ezekiel reveal symptoms suggestive of stroke. Jacob suffered from sciatica, and the child of the Shunnamite woman in II Kings had a subarachnoid hemorrhage. These instances among others found in the Old Testament of the Bible offer newer insights on the history of current neurological diseases.

No abstract